363 related articles for article (PubMed ID: 17177422)
21. Total synthesis of fostriecin (CI-920).
Boger DL; Ichikawa S; Zhong W
J Am Chem Soc; 2001 May; 123(18):4161-7. PubMed ID: 11457179
[TBL] [Abstract][Full Text] [Related]
22. Formal total synthesis of fostriecin by 1,4-asymmetric induction with an alkyne-cobalt complex.
Hayashi Y; Yamaguchi H; Toyoshima M; Okado K; Toyo T; Shoji M
Chemistry; 2010 Sep; 16(33):10150-9. PubMed ID: 20645347
[TBL] [Abstract][Full Text] [Related]
23. Antitumor antibiotic fostriecin covalently binds to cysteine-269 residue of protein phosphatase 2A catalytic subunit in mammalian cells.
Takeuchi T; Takahashi N; Ishi K; Kusayanagi T; Kuramochi K; Sugawara F
Bioorg Med Chem; 2009 Dec; 17(23):8113-22. PubMed ID: 19857968
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of the C1-C12 fragment of fostriecin.
Cossy J; Pradaux F; BouzBouz S
Org Lett; 2001 Jul; 3(14):2233-5. PubMed ID: 11440587
[TBL] [Abstract][Full Text] [Related]
25. Screening for apoptosis inducers in microbial products and induction of apoptosis by cytostatin.
Yamazaki K; Amemiya M; Ishizuka M; Takeuchi T
J Antibiot (Tokyo); 1995 Oct; 48(10):1138-40. PubMed ID: 7490221
[TBL] [Abstract][Full Text] [Related]
26. The predicted beta12-beta13 loop is important for inhibition of PP2Acalpha by the antitumor drug fostriecin.
Evans DR; Simon JA
FEBS Lett; 2001 Jun; 498(1):110-5. PubMed ID: 11389908
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and Cytotoxicity Evaluation of C4- and C5-Modified Analogues of the α,β-Unsaturated Lactone of Pironetin.
Huang DS; Wong HL; Georg GI
ChemMedChem; 2017 Apr; 12(7):520-528. PubMed ID: 28261964
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of PP2A, but not PP5, mediates p53 activation by low levels of okadaic acid in rat liver epithelial cells.
Messner DJ; Romeo C; Boynton A; Rossie S
J Cell Biochem; 2006 Sep; 99(1):241-55. PubMed ID: 16598789
[TBL] [Abstract][Full Text] [Related]
29. Purification of protein phosphatase 4 catalytic subunit: inhibition by the antitumour drug fostriecin and other tumour suppressors and promoters.
Hastie CJ; Cohen PT
FEBS Lett; 1998 Jul; 431(3):357-61. PubMed ID: 9714542
[TBL] [Abstract][Full Text] [Related]
30. New antitumour agents with α,β-unsaturated δ-lactone scaffold: Synthesis and antiproliferative activity of (-)-cleistenolide and analogues.
Benedeković G; Kovačević I; Popsavin M; Francuz J; Kojić V; Bogdanović G; Popsavin V
Bioorg Med Chem Lett; 2016 Jul; 26(14):3318-3321. PubMed ID: 27231128
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and evaluation of C2 functionalized analogs of the α-tubulin-binding natural product pironetin.
Huang DS; Wong HL; Georg GI
Bioorg Med Chem Lett; 2018 Sep; 28(16):2789-2793. PubMed ID: 29138028
[TBL] [Abstract][Full Text] [Related]
32. Fostriecin-mediated G2-M-phase growth arrest correlates with abnormal centrosome replication, the formation of aberrant mitotic spindles, and the inhibition of serine/threonine protein phosphatase activity.
Cheng A; Balczon R; Zuo Z; Koons JS; Walsh AH; Honkanen RE
Cancer Res; 1998 Aug; 58(16):3611-9. PubMed ID: 9721869
[TBL] [Abstract][Full Text] [Related]
33. Anticancer activity and protein phosphatase 1 and 2A inhibition of a new generation of cantharidin analogues.
Sakoff JA; Ackland SP; Baldwin ML; Keane MA; McCluskey A
Invest New Drugs; 2002 Feb; 20(1):1-11. PubMed ID: 12003183
[TBL] [Abstract][Full Text] [Related]
34. Enantio- and stereoselective route to the phoslactomycin family of antibiotics: formal synthesis of (+)-fostriecin and (+)-phoslactomycin B.
Sarkar SM; Wanzala EN; Shibahara S; Takahashi K; Ishihara J; Hatakeyama S
Chem Commun (Camb); 2009 Oct; (39):5907-9. PubMed ID: 19787137
[TBL] [Abstract][Full Text] [Related]
35. The discovery of potent antitumor agent C11-deoxypsymberin/irciniastatin A: total synthesis and biology of advanced psymberin analogs.
Huang X; Shao N; Huryk R; Palani A; Aslanian R; Seidel-Dugan C
Org Lett; 2009 Feb; 11(4):867-70. PubMed ID: 19199777
[TBL] [Abstract][Full Text] [Related]
36. Cytostatin, a novel inhibitor of cell adhesion to components of extracellular matrix produced by Streptomyces sp. MJ654-NF4. I. Taxonomy, fermentation, isolation and biological activities.
Amemiya M; Ueno M; Osono M; Masuda T; Kinoshita N; Nishida C; Hamada M; Ishizuka M; Takeuchi T
J Antibiot (Tokyo); 1994 May; 47(5):536-40. PubMed ID: 8040050
[TBL] [Abstract][Full Text] [Related]
37. Okadaic acid overcomes the blocked cell cycle caused by depleting Cdc2-related kinases in Trypanosoma brucei.
Li Z; Tu X; Wang CC
Exp Cell Res; 2006 Nov; 312(18):3504-16. PubMed ID: 16949574
[TBL] [Abstract][Full Text] [Related]
38. Positive regulation of IkappaB kinase signaling by protein serine/threonine phosphatase 2A.
Kray AE; Carter RS; Pennington KN; Gomez RJ; Sanders LE; Llanes JM; Khan WN; Ballard DW; Wadzinski BE
J Biol Chem; 2005 Oct; 280(43):35974-82. PubMed ID: 16126728
[TBL] [Abstract][Full Text] [Related]
39. Protein phosphatase inhibitors calyculin A and fostriecin protect rabbit cardiomyocytes in late ischemia.
Armstrong SC; Gao W; Lane JR; Ganote CE
J Mol Cell Cardiol; 1998 Jan; 30(1):61-73. PubMed ID: 9500865
[TBL] [Abstract][Full Text] [Related]
40. Total synthesis of fostriecin (CI-920) via a convergent route.
Miyashita K; Ikejiri M; Kawasaki H; Maemura S; Imanishi T
Chem Commun (Camb); 2002 Apr; (7):742-3. PubMed ID: 12119701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
